These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 32239690)

  • 1. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Lord R; Jones AM; Horsley A
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD009529. PubMed ID: 32239690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM; Lord R
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009529. PubMed ID: 26789750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.
    Regan KH; Bhatt J
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD009876. PubMed ID: 30997925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.
    Regan KH; Bhatt J
    Cochrane Database Syst Rev; 2016 Nov; 11():CD009876. PubMed ID: 27804115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.
    Regan KH; Bhatt J
    Cochrane Database Syst Rev; 2014 Oct; (10):CD009876. PubMed ID: 25342425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis.
    Frost F; Shaw M; Nazareth D
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD013079. PubMed ID: 31194880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Smith S; Waters V; Jahnke N; Ratjen F
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis.
    Frost F; Shaw M; Nazareth D
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013079. PubMed ID: 34889457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
    Smith S; Ratjen F; Remmington T; Waters V
    Cochrane Database Syst Rev; 2020 May; 5(5):CD006961. PubMed ID: 32412092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006961. PubMed ID: 28628280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
    Amin R; Waters V
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD009249. PubMed ID: 27415821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
    Amin R; Jahnke N; Waters V
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009249. PubMed ID: 32189337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD005405. PubMed ID: 27412131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis.
    St Denis M; Ramotar K; Vandemheen K; Tullis E; Ferris W; Chan F; Lee C; Slinger R; Aaron SD
    Chest; 2007 Apr; 131(4):1188-96. PubMed ID: 17426227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of intravenous antibiotic therapy in people with cystic fibrosis.
    Abbott L; Plummer A; Hoo ZH; Wildman M
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD006682. PubMed ID: 31487382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
    Amin R; Waters V
    Cochrane Database Syst Rev; 2014 Apr; (4):CD009249. PubMed ID: 24696136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.